A new study on the use of hypofractionated whole-breast irradiation (HF-WBI) for early-stage breast cancer patients found HF-WBI increased 17.4 percent from 2004 to 2011. Patients are also more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live ?50 miles away from a cancer center. The study was published in the Dec. 1, 2014, issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).